Abstract

Intravenous Physical Compatibility of Heparin Sodium and Furosemide

Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D

Issue: Nov/Dec 2022 - Volume 26, Number 6

Page(s): 522-526

Download in electronic PDF format for $75
  • Intravenous Physical Compatibility of Heparin Sodium and Furosemide Page 1
  • Intravenous Physical Compatibility of Heparin Sodium and Furosemide Page 2
  • Intravenous Physical Compatibility of Heparin Sodium and Furosemide Page 3
  • Intravenous Physical Compatibility of Heparin Sodium and Furosemide Page 4
  • Intravenous Physical Compatibility of Heparin Sodium and Furosemide Page 5

Abstract

Continuous infusions of heparin and furosemide are often required for hospitalized patients to treat cardiac-related disease states. Concomitant infusion of heparin and furosemide through the same intravenous line minimizes the need for multiple intravenous sites. For concomitant infusions to be administered, knowledge of the physical compatibility for intravenous medications is imperative for patient safety and administering medications to maximize their effectiveness. Currently, heparin and furosemide are listed as Y-site compatible, but precipitation was reported at a large academic medical center, which questions this compatibility. This study investigated the in vitro physical compatibility of heparin sodium premix 25,000 units/250 mL in dextrose 5% water from two different manufacturers with furosemide 40 mg/4 mL at concentrations of 4:1 for heparin sodium and furosemide. The admixtures were prepared in triplicate using aseptic technique, stored at 19°C to 24°C and examined for visual precipitation, turbidity, and pH change at baseline, 1, 5, 8, 24, and 48 hours. Heparin sodium, B. Braun Medical Inc. or Hospira, Inc. solutions, and furosemide admixtures revealed changes over 48 hours. Changes in visual appearance, absorbance, and pH were observed at hour 5 compared to baseline for the B. Braun Medical Inc. admixture. The Hospira, Inc. admixture revealed visual changes by hour 48, but demonstrative changes in absorbance and pH did not occur. Our observations found demonstrative changes in physical compatibility in the admixtures of heparin sodium and furosemide at a ratio of 4:1. The findings suggest that a combination of the solutions in this study be avoided until further research is completed.    

Related Keywords

  • heparin sodium
  • continuous intravenous infusion
  • thromboembolism
  • furosemide
  • loop diuretic
  • drug admixture
  • Y-site compatibility
  • physical stability
  • chemical stability
  • physical compatibility
  • drug trapping
  • precipitates
  • excipients
  • turbidity

Related Categories

  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • CARDIOLOGY
  • HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2022
Pg. 522-526
Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Jan/Feb 2021
Pg. 52-61
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Nov/Dec 2007
Pg. 520-524
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2020
Pg. 238-241
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Author(s): Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
May/Jun 2020
Pg. 242-245
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Author(s): Ngim Kenley, Patel Jalpa
Mar/Apr 2025
Pg. 121
Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s):
Mar/Apr 2014
Pg. 152-158
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Author(s): Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
Jul/Aug 2008
Pg. 368-371
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jan/Feb 1998
Pg. 79-82
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion
Author(s): Bhatt-Mehta Varsha, Hirata Stacy
May/Jun 2022
Pg. 248-254
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
Mar/Apr 2008
Pg. 156-160
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Jan/Feb 2009
Pg. 78-80
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
May/Jun 2004
Pg. 228-230
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.
Author(s): Xu Quanyun A, Trissel Lawrence A, Pham Lien
Jul/Aug 2010
Pg. 346-349
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Author(s): Baker Daniel S, Waldrop Bruce, Arnold John
May/Jun 2011
Pg. 259-261
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Author(s): Jasti Bhaskara R, Saraf Poonam
Sep/Oct 2019
Pg. 414-417
Stability of Furosemide 5 mg/mL in Polypropylene Syringes
Author(s): van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
Nov/Dec 2020
Pg. 473-478
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 276-278
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A